Registry-randomized Comparison of Rehabilitation Regimens After Flexor Tendon Injury in the Thumb

May 31, 2026 updated by: Maria Wilcke, Karolinska Institutet

Registry-randomized Comparison of Rehabilitation Regimens After Flexor Pollicis Longus Injury in the Thumb

Flexor tendon injuries in the thumb occur across all ages and genders. Each year, approximately 400 patients undergo surgery for a flexor tendon injury in Sweden. These injuries are exclusively treated at one of the seven specialized hand surgery clinics, as the surgery is technically demanding, and postoperative rehabilitation is critical, specialized, and requires expertise from hand therapists. To prevent tendon adhesions and stiffness in the thumb or fingers, controlled active motion therapy is usually initiated within a few days after surgery. Studies on finger flexor tendon injuries have shown that early active movement therapy leads to better mobility compared to immobilization. Consequently, early active training is now the standard treatment following flexor tendon repair. However, during postoperative rehabilitation, the repaired flexor tendon may rupture, often necessitating revision surgery.

The rupture rate after flexor tendon repair in the thumb is approximately three times higher than in other fingers (10% vs. 3%). While most studies on flexor tendon injuries focus on finger tendons, research on the outcomes of thumb flexor tendon injuries is limited. The biomechanics and anatomy of the thumb's flexor tendon differ significantly from those of finger tendons.

The objective of this study is to determine whether the rupture rate following thumb flexor tendon surgery can be reduced by immobilizing the thumb in a cast for four weeks postoperatively, compared to standard early active motion therapy, without negatively affecting joint mobility and thumb strength. Additionally, the study will evaluate patient-reported outcomes one year post-surgery for both rehabilitation regimens (immobilization vs. mobilization).

This study is a registry-randomized clinical trial (RRCT) involving five hand surgery clinics in Sweden. Data following randomization between the two rehabilitation protocols will be collected through follow-up in the Swedish National Hand Surgery Quality Registry (HAKIR).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

380

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Maria Wilcke, MD, Associate professor
  • Phone Number: +46812362022
  • Email: maria.wilcke@ki.se

Study Locations

      • Linköping, Sweden
        • Recruiting
        • Hand- och plastikkirurgiska kliniken Linköpings Universitetssjukhus
        • Contact:
          • Erika Nyman, MD, Associate professor
          • Phone Number: +4610-105 96 90
      • Stockholm, Sweden
        • Recruiting
        • Handkirurgiska kliniken Södersjukhuset
        • Contact:
          • Maria Wilcke, MD, Associate professor
          • Phone Number: +4681236022
          • Email: maria.wilcke@ki.se
      • Umeå, Sweden
        • Recruiting
        • Handkirurgiska kliniken Norrlands Universitetssjukhus
        • Contact:
      • Uppsala, Sweden
        • Recruiting
        • Handkirugiska kliniken Uppsala Akademiska Sjukhus
        • Contact:
      • Örebro, Sweden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Complete laceration of the thumb flexor tendon (Flexor Pollicis Longus; FPL) within zone 1 and 2.

Age over 15 years. Minors (<18 years) are considered to have sufficient maturity to understand the implications of the research.

Swedish-speaking / able to understand spoken and written Swedish. Surgery performed within 14 days from the time of injury.

Exclusion Criteria:

Tendon injury with a defect requiring tendon grafting. Another complete tendon injury in the same hand. Extensive associated injuries, such as fracture, vascular injury with circulatory impairment, large skin defect, or preoperative signs of infection. Patient deemed unsuitable for early active motion therapy due to factors such as lack of cooperation, cognitive impairment, or substance abuse issues.

Patient declines follow-up in the HAKIR quality registry. Wound infection making early active motion therapy inappropriate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Early active motion
Early active motion 2-5 days postoperatively.
Early active motion training after operated FPL injury
Active Comparator: Immobilisation in plaster cast 4 weeks
Immobilisation in plaster cast 4 weeks postoperatively
Immobilisation in plaster cast 4 weeks after operated FPL injury

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tendon rupture rate
Time Frame: Within one year after operation
Clinically diagnosed rupture of an operated flexor pollicis longus injury
Within one year after operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active range of motion in the joints of the operated thumb MCP joint
Time Frame: 3 and 12 months postoperatively
Active range of motion of the MCP joint of the operated thumb measured with a goniometer
3 and 12 months postoperatively
Active range of motion of the IP-joint in the opererated thumb
Time Frame: 3 and 12 months postoperatively
Measured with a goniometer
3 and 12 months postoperatively
Grip strength
Time Frame: 3 and 12 months postoperatively
Measured using a Jamar dynamometer and compared to the uninjured side.gauge.
3 and 12 months postoperatively
Key pinch strength
Time Frame: 3 and 12 months postoperatively
Key pinch between the thumb and index finger assessed with a pinch gauge.
3 and 12 months postoperatively
HQ-8 questionnaire
Time Frame: 3 and 12 months postoperatively
A Patient-rated outcome measurse (PROM).The HAKIR questionnaire (HQ-8) consists of seven questions regarding symptoms in the operated hand, such as aching, pain, numbness, weakness, and cold sensitivity, as well as one question on perceived hand function. All questions are answered on a 0-100 scale (0, 10, 20, etc.). An additional question in the questionnaire addresses satisfaction with the surgical outcome, rated from completely dissatisfied to completely satisfied.
3 and 12 months postoperatively
Quick DASH
Time Frame: 3 and 12 months postoperatively
A patient-rated outcome measure (PROM). The short version of the Disabilities of the Arm, Shoulder, and Hand (QuickDASH) contains 11 questions covering activity limitations, symptoms, and participation. The responses are summed into a total score ranging from 0 to 100, where 100 represents maximum perceived disability of the hand and arm.
3 and 12 months postoperatively
Overall satisfaction with rehabilitation
Time Frame: 3 and 12 months
Five-point Likert scale of overall satisfaction with rehabilitation: the five response options are: (1) Yes, to a very large extent, (2) Yes, to a large extent, (3) To a certain extent, (4) To a small extent, and (5) Not at all.
3 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

December 31, 2031

Study Completion (Estimated)

December 31, 2031

Study Registration Dates

First Submitted

February 7, 2025

First Submitted That Met QC Criteria

February 14, 2025

First Posted (Actual)

February 20, 2025

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 31, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified data might be shared upon request for metaanalyses.

IPD Sharing Time Frame

After the results are analyzed and publish and 10 years ahead

IPD Sharing Access Criteria

Researchers with an ethical permitt, as descibed above, by request to maria.wilcke@ki.se

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Flexor Tendon Rupture

Clinical Trials on Early active motion training after operated FPL injury

Subscribe